1. Home
  2. BBIO vs NWS Comparison

BBIO vs NWS Comparison

Compare BBIO & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.18

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$29.70

Market Cap

16.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBIO
NWS
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
16.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BBIO
NWS
Price
$74.18
$29.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
7
Target Price
$76.24
$37.95
AVG Volume (30 Days)
2.0M
841.3K
Earning Date
10-29-2025
02-04-2026
Dividend Yield
N/A
0.68%
EPS Growth
N/A
230.83
EPS
N/A
2.06
Revenue
$353,780,000.00
$8,500,000,000.00
Revenue This Year
$128.44
$5.10
Revenue Next Year
$76.14
$3.24
P/E Ratio
N/A
$12.96
Revenue Growth
62.46
2.20
52 Week Low
$25.34
$26.25
52 Week High
$76.51
$35.58

Technical Indicators

Market Signals
Indicator
BBIO
NWS
Relative Strength Index (RSI) 62.39 53.36
Support Level $72.73 $29.14
Resistance Level $76.51 $30.03
Average True Range (ATR) 2.37 0.52
MACD -0.30 0.10
Stochastic Oscillator 66.40 75.84

Price Performance

Historical Comparison
BBIO
NWS

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About NWS News Corporation Class B

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: